The Heart Foundation and the Cardiac Society of Australia and New Zealand (CSANZ) have released 'Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated July 2011'. The guidelines feature updated evidence related to:
* use of B-type natriuretic peptide (BNP), including plasma-BNP or N-terminal pro-BNP measurement
* physicial activity and rehabilitation
* pharmaco-therapy
* use of polyunsaturated fatty acids in treatment of systolic heart failure
* use of devices
* treatment of cardiac arrhythmias in patients
* multidisciplinary care and post-discharge management programs
No comments:
Post a Comment